Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nitric oxide drives proteomic diversity through alternative splicing.

Molecular cell·2026
Same author

The protein denitrosylase SCoR2 regulates lipogenesis and fat storage.

Science signaling·2025
Same author

The denitrosylase SCoR2 controls cardioprotective metabolic reprogramming.

eLife·2025
Same author

S-Nitrosylation of GPCR Regulatory Machinery as a Mechanism to Bias Signaling.

Handbook of experimental pharmacology·2025
Same author

S-nitrosylation of pVHL regulates β<sub>2</sub> adrenergic receptor function.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

Transcriptional responses to nitric oxide are widescale and source-dependent.

The Journal of biological chemistry·2025
Same journal

Increased rates of hybridization in swordtails are associated with water pollution.

Current biology : CB·2026
Same journal

Visual uncertainty and task demands shape active sensing strategies in mice.

Current biology : CB·2026
Same journal

An adaptable, self-organizing, single-cell morphology circuit optimizes suctorian predatory trap structure.

Current biology : CB·2026
Same journal

Temporal tuning of switch-like virulence expression resolves environmental uncertainty through phenotypic heterogeneity.

Current biology : CB·2026
Same journal

An abstract relational map emerges in the human medial prefrontal cortex with consolidation.

Current biology : CB·2026
Same journal

Phloem evolved gradually and asynchronously to xylem in early vascular plants.

Current biology : CB·2026
See all related articles

Related Experiment Video

Updated: Jun 18, 2026

Generation of Organ-conditioned Media and Applications for Studying Organ-specific Influences on Breast Cancer Metastatic Behavior
09:44

Generation of Organ-conditioned Media and Applications for Studying Organ-specific Influences on Breast Cancer Metastatic Behavior

Published on: June 13, 2016

Metastasis: wherefore arf thou?

Richard T Premont1, Robert Schmalzigaug

  • 1Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA. Richard.Premont@Duke.edu

Current Biology : CB
|December 2, 2009
PubMed
Summary
This summary is machine-generated.

The small GTP-binding protein, ADP-ribosylation factor 6 (Arf6), regulates cell motility in metastasis. This study reveals Arf6 also controls the release of microvesicles from the cell membrane, impacting cancer spread.

More Related Videos

Tracking Tumor Cell Dissemination from Lung Metastases Using Photoconversion
05:23

Tracking Tumor Cell Dissemination from Lung Metastases Using Photoconversion

Published on: July 7, 2023

A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer
07:35

A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer

Published on: December 26, 2016

Related Experiment Videos

Last Updated: Jun 18, 2026

Generation of Organ-conditioned Media and Applications for Studying Organ-specific Influences on Breast Cancer Metastatic Behavior
09:44

Generation of Organ-conditioned Media and Applications for Studying Organ-specific Influences on Breast Cancer Metastatic Behavior

Published on: June 13, 2016

Tracking Tumor Cell Dissemination from Lung Metastases Using Photoconversion
05:23

Tracking Tumor Cell Dissemination from Lung Metastases Using Photoconversion

Published on: July 7, 2023

A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer
07:35

A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer

Published on: December 26, 2016

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • The small GTP-binding protein Arf6 is a known regulator of the actin cytoskeleton.
  • Arf6 plays a critical role in cell motility, a process crucial for cancer metastasis.

Purpose of the Study:

  • To investigate the role of Arf6 in the release of plasma-membrane-derived microvesicles.
  • To further elucidate the mechanisms by which Arf6 contributes to cancer metastasis.

Main Methods:

  • The study likely involved cell-based assays to observe Arf6 function.
  • Techniques to measure microvesicle release and analyze their content may have been employed.

Main Results:

  • A recent study identified Arf6 as a regulator of plasma-membrane-derived microvesicle release.
  • This adds a new function for Arf6 in the context of cancer metastasis.

Conclusions:

  • Arf6 has a multifaceted role in cancer metastasis, extending beyond cytoskeletal regulation.
  • The regulation of microvesicle release by Arf6 represents a novel mechanism contributing to cancer progression.